Therapeutical Management for Ocular Rosacea

Lopez-Valverde, G. ; Garcia-Martin, E. (Universidad de Zaragoza) ; Larrosa-Poves, J.M. (Universidad de Zaragoza) ; Polo-Llorens, V. (Universidad de Zaragoza) ; Pablo-Julvez, L.E. (Universidad de Zaragoza)
Therapeutical Management for Ocular Rosacea
Resumen: Purpose: The purpose of this study is to describe a case of ocular rosacea with a very complex evolution. Rosacea is a chronic dermatological disease that may affect the ocular structures up to 6-72% of all cases. This form is often misdiagnosed, which may lead to long inflammatory processes with important visual consequences for affected patients. Therefore, an early diagnosis and an adequate treatment are important. Methods: We report the case of a 43-year-old patient who had several relapses of what seemed an episode of acute bacterial conjunctivitis. Two weeks later, he developed a corneal ulcer with a torpid evolution including abundant intrastromal infiltrators and calcium deposits. He was diagnosed with ocular rosacea and treated with systemic doxycycline and topical protopic. Results: A coating with amniotic membrane was placed in order to heal the ulcer, but a deep anterior lamellar keratoplasty to restore the patient''s vision because of the corneal transparency loss was necessary. Conclusions: Ocular rosacea includes multiple ophthalmic manifestations ranging from inflammation of the eyelid margin and blepharitis to serious corneal affectations. A delayed diagnosis can result in chronic inflammatory conditions including keratinization and loss of corneal transparency, which lead to important visual sequelae for affected patients. (C) 2016 The Author(s) Published by S. Karger AG, Basel
Idioma: Inglés
DOI: 10.1159/000446104
Año: 2017
Publicado en: Case reports in ophthalmology 7, 1 (2017), 237-242
ISSN: 1663-2699

Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Oftalmología (Departamento de Cirugía, Ginecología y Obstetricia)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.

Exportado de SIDERAL (2018-04-20-12:20:53)

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Oftalmología

 Registro creado el 2018-04-20, última modificación el 2018-04-20

Versión publicada:
Valore este documento:

Rate this document:
(Sin ninguna reseña)